Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 6/20 | 0.37 |
| ▸ | ADRA2B | P18089 | 6/20 | 0.37 |
| ▸ | ADRA2C | P18825 | 6/20 | 0.37 |
| ▸ | HTR1A | P08908 | 4/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3910226 | 0.84 | DRD4 (0.38) | ALDH1A1GLAADRA2AADRA2BADRA2C | |
| SCHEMBL7123428 | 0.81 | ALDH1A1 (0.44) | ALDH1A1GLAADRA2AADRA2BADRA2C | |
| SCHEMBL3910102 | 0.80 | ALDH1A1 (0.38) | ALDH1A1GLAADRA2AADRA2BADRA2C | |
| SCHEMBL14199651 | 0.77 | ALDH1A1 (0.46) | ALDH1A1GLAHTR1AKCNH2DRD4 | |
| SCHEMBL14199653 | 0.76 | DRD4 (0.51) | ALDH1A1GLAHTR1ADRD4SLC6A2 | |
| SCHEMBL7114249 | 0.76 | CYP2D6 (0.50) | ALDH1A1GLAKCNH2SLC6A2HRH3 | |
| SCHEMBL3372443 | 0.76 | ALDH1A1 (0.46) | ALDH1A1GLADRD4SLC6A2TDP1 | |
| SCHEMBL1312619 | 0.76 | ALDH1A1 (0.46) | ALDH1A1GLADRD4SLC6A2TDP1 | |
| SCHEMBL6305830 | 0.76 | ALDH1A1 (0.46) | ALDH1A1GLADRD4SLC6A2TDP1 | |
| SCHEMBL7123430 | 0.73 | ALDH1A1 (0.47) | ALDH1A1GLAADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6670474-B2 | Such as bis-1,2-(2-(2,3-epoxypropyl)phenoxy)ethane; chemical intermediates for formation of epoxy resins | PEWS R GARTH (US) | 2003-12-30 | — | — | US | claimed |
| US-20020151731-A1 | Novel epoxide derivatives of allylarylphenols | PEWS R GARTH (US) | 2002-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151731-A1 | Novel epoxide derivatives of allylarylphenols | EPHX2, CBR3, CYP4X1 | ALDH1A1 578/4885GLA 2736/4885ADRA2A 223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.